Sera were collected from 238 high-school students in Prince Edward Island for the determination of immune status before an anticipated measles outbreak. In addition, history of vaccination status and measles infection was obtained. In the subsequent outbreak, 28 students did contract measles. Specificity for hemagglutination inhibition (HI), antihemolysin (AH), and enzyme-linked immunosorbent assay (ELISA) 
Although the reported occurrence of measles in 1983 in Canada and the United States reached the lowest levels ever recorded, the disease continues to be an important cause of morbidity and mortality in underdeveloped countries (2) . Kaartinen (6) , for example, reported an epidemic in Ethiopia with a mortality rate estimated at 20%, in which 4,000 people were thought to have died. Measles has been targeted for global eradication (5) , and to achieve this goal, highly sensitive and specific tests may be required to assess the susceptible population and to monitor vaccine efficacy (8, 13) .
The hemagglutination inhibition (HI) test is commonly used to measure measles antibody for the determination of immune status. However, this test has been shown to be less sensitive than the plaque neutralization (Nt) test (1) and the enzyme-linked immunosorbent assay (ELISA) test (14) . Alternatively, Norrby and Gollmar (10) AH test. The hemolytic activity of measles antigen was assayed by a modification of the technique of Carrigan and Johnson (3). A 1-ml volume of measles hemagglutinin antigen was mixed with 0.20 ml of 50% (vol/vol) African green monkey erythrocytes and incubated at 37°C for 30 min. The absorbance (540 nm) of the supernatant fluid (900 x g for 10 min) was read at 0 and 30 min of incubation. The optical density change reflected the hemolysis activity. The minimum hemolysin concentration used was that producing an optical density change of 0.40. For sensitization, 2 ml of antigen diluted 1:2 in PBS was mixed with 0.2 ml of 50% African green monkey erythrocyte suspension and incubated at 37°C for 30 min. The sensitized cells were centrifuged (900 x g for 10 min) and suspended in 1.0 ml of PBS with 1.0 ml of goat anti-human immunoglobulin G (IgG; Miles Laboratories, Inc., Rexdale, Ontario, Canada). Agarose (1%) in PBS (Agarose Il; Sigma Chemical Co., St. Louis, Mo.) was autoclaved for 10 min at 115°C. The sensitized cells, antihuman IgG, and 13 ml of molten agarose were combined at 43°C and poured into petri plates (9 by 9 cm). Wells 
